Hutchmed (china) LimitedHKEX: 13

Monthly Return of Equity Issuer on Movements in Securities for the month ended September 30, 2026

Oct 2, 2026 at 8:35 AM UTC · Issued by Hutchmed (china) Limited via HKEXnews

Watch Hutchmed (china) explain itHUTCHMED (China) Limited (HCM) Q2 2026 Earnings Call · Replay · Jul 30

HKEX: 13

View Attachment

View original source (HKEXnews)

Earlier from Hutchmed (china)

VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Submission of US NDA for ORPATHYS plus TAGRISSO in MET Driven EGFR-Mutated Lung CancerSep 29
VOLUNTARY ANNOUNCEMENT - HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid TumorsSep 28
HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer TherapySep 3
HUTCHMED Reports 2026 Interim ResultsJul 30

All Hutchmed (china) news releases